Alfuzosin: Difference between revisions

From Citizendium
Jump to navigation Jump to search
imported>Tom Morris
(+subpages)
imported>Robert Badgett
No edit summary
Line 2: Line 2:


In [[medicine]], '''alfuzosin''' is a selective antagonist of alpha1-[[adrenergic receptor]]s.
In [[medicine]], '''alfuzosin''' is a selective antagonist of alpha1-[[adrenergic receptor]]s.
==History==
Uroxatral brand of alfuzosin was approved by the [[Food and Drug Administration]] in the [[United States]] with a [http://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/NewDrugApplicationNDA/ New Drug Application] (NDA) in 2003.<ref>[http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchType=BasicSearch&Search_Button=Submit&searchTerm=021287 Drugs@FDA]. U S Food and Drug Administration</ref> A generic version was approved with a [http://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/ Abbreviated New Drug Application] (ANDA) in 2009.<ref>[http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchType=BasicSearch&Search_Button=Submit&searchTerm=079013 Drugs@FDA]. U S Food and Drug Administration</ref>
==Pharmacology==
===Administration===
===Distribution===
===Metabolism===
===Excretion===
===Toxicity===


==External links==
==External links==
{{CZMed}}
{{CZMed}}
==References==
<references/>

Revision as of 15:35, 14 December 2009

This article is a stub and thus not approved.
Main Article
Discussion
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
This editable Main Article is under development and subject to a disclaimer.

In medicine, alfuzosin is a selective antagonist of alpha1-adrenergic receptors.

History

Uroxatral brand of alfuzosin was approved by the Food and Drug Administration in the United States with a New Drug Application (NDA) in 2003.[1] A generic version was approved with a Abbreviated New Drug Application (ANDA) in 2009.[2]

Pharmacology

Administration

Distribution

Metabolism

Excretion

Toxicity

External links

The most up-to-date information about Alfuzosin and other drugs can be found at the following sites.


References

  1. Drugs@FDA. U S Food and Drug Administration
  2. Drugs@FDA. U S Food and Drug Administration